Mandate

Vinge has advised Lone Star Fund and Stark Group in connection with the sale of the Stark Group to CVC Capital Partners.

Headquartered in Denmark, STARK Group is a leading B2B distributor of heavy building materials for the construction industry in the Nordics and Germany, with a focus on serving professional craftsmen. The business partners with 10,000 suppliers to serve c. 235,000 customers from more than 400 locations in Denmark (incl. Greenland), Sweden, Norway, Finland, and Germany. The transaction is subject to customary conditions and approvals and is expected to close in Q2 2021.

Vinge’s team consisted of, among others, Jonas Bergström, Desirée Sjöblom, Vilhelm Rondahl and Amanda Steen (M&A), Michaela Cronemyr and Isabell Nielsen (Agreements), Frida Ställborn and Kristoffer Larson (Real Estate), Sara Strandberg and Caroline Edwall (Employment), Sofia Bergenstråhle (IP), Ludvig Wettergren and Jolinn Uhlin (Financial Arrangements), Fredrika Hjelmberg (IT), Nicklas Thorgerzon (GDPR), Lina Österberg (Permits), Tove Lövgren Frisk (Compliance) and the VDR assistant Carl Bruneheim.

 

Related

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.
January 24, 2025

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.
January 22, 2025